Published Date: 02 Mar 2023
A deep learning model called Sybil can predict future lung cancer risk based on a low-dose chest CT scan and identify people who are likely to benefit from regular treatment.
Read Full NewsA meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.
Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.
Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.
Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.
Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.
1.
ALK-positive lung cancer trial results show unprecedented progression-free survival.
2.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
3.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
4.
Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.
5.
Resection for Early Liver Cancer Tied to Improved Survival.
1.
The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough
2.
Survival Rate Dynamics in Hematologic and Solid Malignancies
3.
Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025
4.
The Capmist DM: A Revolutionary Way to Combat Dry Mouth
5.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation